DE69808921D1 - 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOL-1-ACETAMID-DERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE ANWENDUNG - Google Patents

4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOL-1-ACETAMID-DERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE ANWENDUNG

Info

Publication number
DE69808921D1
DE69808921D1 DE69808921T DE69808921T DE69808921D1 DE 69808921 D1 DE69808921 D1 DE 69808921D1 DE 69808921 T DE69808921 T DE 69808921T DE 69808921 T DE69808921 T DE 69808921T DE 69808921 D1 DE69808921 D1 DE 69808921D1
Authority
DE
Germany
Prior art keywords
pyridazino
indol
dihydro
oxo
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69808921T
Other languages
English (en)
Other versions
DE69808921T2 (de
Inventor
Yannick Evanno
Laurent Dubois
Mireille Sevrin
Frank Marguet
Jacques Froissant
Regine Bartsch
Catherine Gille
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of DE69808921D1 publication Critical patent/DE69808921D1/de
Application granted granted Critical
Publication of DE69808921T2 publication Critical patent/DE69808921T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • A61P25/12Antiepileptics; Anticonvulsants for grand-mal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
DE69808921T 1997-07-30 1998-07-28 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOL-1-ACETAMID-DERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE ANWENDUNG Expired - Lifetime DE69808921T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709692A FR2766823B1 (fr) 1997-07-30 1997-07-30 Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
PCT/FR1998/001667 WO1999006406A1 (fr) 1997-07-30 1998-07-28 DERIVES DE 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b] INDOLE-1-ACETAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (2)

Publication Number Publication Date
DE69808921D1 true DE69808921D1 (de) 2002-11-28
DE69808921T2 DE69808921T2 (de) 2003-07-03

Family

ID=9509801

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69808921T Expired - Lifetime DE69808921T2 (de) 1997-07-30 1998-07-28 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOL-1-ACETAMID-DERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE ANWENDUNG

Country Status (33)

Country Link
US (1) US6262045B1 (de)
EP (1) EP1000063B1 (de)
JP (1) JP4322421B2 (de)
KR (1) KR100497782B1 (de)
CN (1) CN1134440C (de)
AR (1) AR013264A1 (de)
AT (1) ATE226584T1 (de)
AU (1) AU736600B2 (de)
BG (1) BG64283B1 (de)
BR (1) BR9811582B1 (de)
CA (1) CA2298522C (de)
CO (1) CO5210883A1 (de)
CZ (1) CZ290011B6 (de)
DE (1) DE69808921T2 (de)
DK (1) DK1000063T3 (de)
EE (1) EE04317B1 (de)
ES (1) ES2186212T3 (de)
FR (1) FR2766823B1 (de)
HK (1) HK1028027A1 (de)
HU (1) HU229430B1 (de)
IL (1) IL133633A (de)
NO (1) NO313963B1 (de)
NZ (1) NZ502361A (de)
PL (1) PL194245B1 (de)
PT (1) PT1000063E (de)
RU (1) RU2197490C2 (de)
SI (1) SI1000063T1 (de)
SK (1) SK283075B6 (de)
TR (1) TR200000278T2 (de)
TW (1) TW506971B (de)
UA (1) UA57088C2 (de)
WO (1) WO1999006406A1 (de)
ZA (1) ZA986786B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788696B1 (fr) 1999-01-26 2004-03-05 Synthelabo Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
GB0000564D0 (en) 2000-01-11 2000-03-01 Merck Sharp & Dohme Therapeutic agents
FR2811990A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2833953B1 (fr) * 2001-12-21 2004-12-03 Sanofi Synthelabo DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2838124B1 (fr) 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
KR20080015077A (ko) * 2005-05-05 2008-02-18 사노피-아벤티스 유.에스. 엘엘씨 안정한 나노입자 제형
WO2007027525A1 (en) * 2005-08-29 2007-03-08 Sanofi-Aventis U.S. Llc Novel crystalline form of a pyridazino [4 , 5-b] indole derivative
SI1926476T1 (sl) * 2005-08-29 2013-07-31 Sanofi-Aventis U.S. Llc Amorfne trdne disperzije 7-kloro-N,N,5-trimetil-4-okso-3-fenil-3,5- dihidro-4H-piridazino/4,5-b/indol-1-acetamida
WO2007038209A2 (en) * 2005-09-23 2007-04-05 Schering Corporation Fused tetracyclic mglur1 antagonists as therapeutic agents
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及***
MX2011001474A (es) * 2008-08-18 2011-03-25 Sanofi Aventis Llc Proceso para preparar polimorfos.
EP2181717A1 (de) 2008-10-28 2010-05-05 Sanofi-Aventis Verwendung von 7-Chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indol-1-Acetamid als Biomarker für periphere Benzodiazepin-Rezeptorverteilung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985560A (en) * 1990-01-12 1991-01-15 American Home Products Corporation Pyridazino(4,5-b)indolizines
GB9411955D0 (en) * 1994-06-15 1994-08-03 Merck Sharp & Dohme Therapeutic agents
US5756501A (en) * 1995-12-13 1998-05-26 American Home Products Corporation Saturated and unsaturated pyridazino 4,5-B! indolizines useful as antidementia agents
FR2754262B1 (fr) 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
SK283075B6 (sk) 2003-02-04
EP1000063A1 (de) 2000-05-17
NO313963B1 (no) 2003-01-06
PL194245B1 (pl) 2007-05-31
EE200000056A (et) 2000-10-16
RU2197490C2 (ru) 2003-01-27
JP2001512122A (ja) 2001-08-21
HUP0002650A3 (en) 2002-09-30
AU8983298A (en) 1999-02-22
CA2298522A1 (en) 1999-02-11
HU229430B1 (en) 2013-12-30
BG64283B1 (bg) 2004-08-31
KR20010022356A (ko) 2001-03-15
CN1265108A (zh) 2000-08-30
BR9811582A (pt) 2000-09-26
NZ502361A (en) 2001-06-29
AU736600B2 (en) 2001-08-02
FR2766823B1 (fr) 1999-10-08
NO20000462L (no) 2000-03-29
UA57088C2 (uk) 2003-06-16
DK1000063T3 (da) 2003-02-24
CN1134440C (zh) 2004-01-14
ES2186212T3 (es) 2003-05-01
ZA986786B (en) 1999-02-02
PL338445A1 (en) 2000-11-06
SK1292000A3 (en) 2000-08-14
PT1000063E (pt) 2003-03-31
BR9811582B1 (pt) 2010-10-19
EE04317B1 (et) 2004-06-15
IL133633A0 (en) 2001-04-30
SI1000063T1 (en) 2003-04-30
ATE226584T1 (de) 2002-11-15
AR013264A1 (es) 2000-12-13
NO20000462D0 (no) 2000-01-28
BG104096A (en) 2000-08-31
FR2766823A1 (fr) 1999-02-05
EP1000063B1 (de) 2002-10-23
TW506971B (en) 2002-10-21
TR200000278T2 (tr) 2000-08-21
CZ2000320A3 (cs) 2000-05-17
CZ290011B6 (cs) 2002-05-15
DE69808921T2 (de) 2003-07-03
HUP0002650A2 (hu) 2001-01-29
CA2298522C (en) 2008-07-15
KR100497782B1 (ko) 2005-06-27
HK1028027A1 (en) 2001-02-02
WO1999006406A1 (fr) 1999-02-11
JP4322421B2 (ja) 2009-09-02
CO5210883A1 (es) 2002-10-30
IL133633A (en) 2004-02-08
US6262045B1 (en) 2001-07-17

Similar Documents

Publication Publication Date Title
DE60001451D1 (de) 1,4-diazabicyclo[3.2.2]nonan-4-carboxylat und carboxamidderivate, ihre herstellung und therapeutische verwendung
ATE258549T1 (de) Oxazolidindion-derivate, ihre herstellung und verwendung
ATE310003T1 (de) Benzodiazepin-derivate, deren herstellung und anwendung
DE59814449D1 (de) Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
ATE231869T1 (de) Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung
ATE332294T1 (de) Dihydro-1,3,5-triazin-diamin-derivate und ihre therapeutische verwendung
DE69901177D1 (de) Platinkomplex, dessen herstellung und dessen therapeutische verwendung
DE69808921D1 (de) 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOL-1-ACETAMID-DERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE ANWENDUNG
DE60103054D1 (de) Phenyloxazol-1,4-diazabicyclo[3.2.2]nonanderivate, ihre herstellung und ihre therapeutische verwendung
DE69713124T2 (de) 1H-PYRIDO[3,4-b]INDOLCARBOXAMIDDERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE VERWENDUNG
DE59710272D1 (de) Neue alpha-hydroxysäurederivate, ihre herstellung und verwendung
DE60100621D1 (de) 4-heteroaryl-1,4-diazabicyclo 3.2.2.]nonane, ihre herstellung und ihre therapeutische anwendung
FI956298A0 (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
DE69330075T2 (de) Oxazolinderivate, ihre Herstellung und Anwendung
NO992676D0 (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
DE59711704D1 (de) Neue carbonsäurederivate, ihre herstellung und verwendung
ATE212346T1 (de) 3-substituierte tetrahydropyridopyrimidinon- derivate, ihre herstellung und verwendung
DE60002043D1 (de) 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]indol-1-carboxamid-derivate, ihre herstellung und therapeutische verwendung
ATE188705T1 (de) 13-substituierte milbemycinderivate, ihre herstellung und verwendung
DE69905714D1 (de) Platinkomplex, dessen herstellung und dessen therapeutische anwendung
ATE184005T1 (de) Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung
DE59501950D1 (de) Isolongifolanol-Derivate, ihre Herstellung und ihre Verwendung
EE200000207A (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine
ATE198192T1 (de) Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung
ATE205841T1 (de) Derivate von 5-naphthalin-1-yl-1,3-dioxanen, ihre herstellung und therapeutische anwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS, PARIS, FR

R082 Change of representative

Ref document number: 1000063

Country of ref document: EP

Representative=s name: TER MEER STEINMEISTER & PARTNER GBR PATENTANWA, DE